BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021;21:245-56. [PMID: 33723416 DOI: 10.1038/s41577-021-00522-1] [Cited by in Crossref: 183] [Cited by in F6Publishing: 191] [Article Influence: 183.0] [Reference Citation Analysis]
Number Citing Articles
1 Cortegiani A, Tripodi VF, Castioni CA, Esposito C, Galdieri N, Monzani R, Rispoli M, Simonini A, Torrano V, Giarratano A, Gratarola A. Timing of surgery and elective perioperative management of patients with previous SARS-CoV-2 infection: a SIAARTI expert consensus statement. J Anesth Analg Crit Care 2022;2:29. [DOI: 10.1186/s44158-022-00058-3] [Reference Citation Analysis]
2 Vályi-nagy I, Uher F, Rákóczi É, Szekanecz Z. Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection? IJMS 2022;23:13951. [DOI: 10.3390/ijms232213951] [Reference Citation Analysis]
3 Chong LC, Khan AM. Historical milestone in 42 years of viral sequencing—Impetus for a community-driven sequencing of global priority pathogens. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1020148] [Reference Citation Analysis]
4 Tsamakis K, Tsiptsios D, Stubbs B, Ma R, Romano E, Mueller C, Ahmad A, Triantafyllis AS, Tsitsas G, Dragioti E. Summarising data and factors associated with COVID-19 related conspiracy theories in the first year of the pandemic: a systematic review and narrative synthesis. BMC Psychol 2022;10:244. [PMID: 36320071 DOI: 10.1186/s40359-022-00959-6] [Reference Citation Analysis]
5 Morstead T, Zheng J, Sin NL, Rights JD, Delongis A. Pandemic stressors and depressive symptoms: Examining within- and between-person effects of neuroticism. Personality and Individual Differences 2022;198:111827. [DOI: 10.1016/j.paid.2022.111827] [Reference Citation Analysis]
6 Alexopoulou L. Nucleic acid-sensing toll-like receptors: Important players in Sjögren’s syndrome. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.980400] [Reference Citation Analysis]
7 Urru S, Sciannameo V, Lanera C, Salaris S, Gregori D, Berchialla P. A topic trend analysis on COVID-19 literature. Digit Health 2022;8:20552076221133696. [PMID: 36325437 DOI: 10.1177/20552076221133696] [Reference Citation Analysis]
8 Baklaushev VP, Yusubalieva GM, Bychinin MV, Yusubalieva SM, Kalsin VA, Troitskiy AV. A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains. Journal of Clinical Practice 2022;13:43-55. [DOI: 10.17816/clinpract111120] [Reference Citation Analysis]
9 Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, Gouma S, Manzoni TB, Hicks P, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, Brock A, Weaver J, Millar JS, DerOhannessian S, Greenplate AR, Frank I, Rader DJ, Wherry EJ, Bates P, Hensley SE; UPenn COVID Processing Unit. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep 2022;41:111496. [PMID: 36261003 DOI: 10.1016/j.celrep.2022.111496] [Reference Citation Analysis]
10 Leung SJ, Chiang BJ, Roseman JT, Klausner A. The Utility of Social Media on Urology Residency Doximity Rankings. Cureus 2022. [DOI: 10.7759/cureus.29666] [Reference Citation Analysis]
11 Kim S, Goh Y, Kang JHB. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore. Global Health 2022;18:82. [PMID: 36131348 DOI: 10.1186/s12992-022-00873-x] [Reference Citation Analysis]
12 Sargsyan K, Mazmanian K, Lim C. A strategy for evaluating antiviral resistance: Application to small molecule drugs/inhibitors against SARS-CoV-2.. [DOI: 10.21203/rs.3.rs-1877306/v2] [Reference Citation Analysis]
13 Ringwald B, Shawar S, Curren C, Mccallister J, Bazan J, Mead C, Kman N. Electronic Health Record-based COVID-19 Interprofessional Case Collaboration. WestJEM 2022;23:789-91. [DOI: 10.5811/westjem.22.2.53886] [Reference Citation Analysis]
14 Fessler SN, Liu L, Chang Y, Yip T, Johnston CS. Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial. J Nutr 2022:nxac154. [PMID: 36084236 DOI: 10.1093/jn/nxac154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Brlić PK, Pavletić M, Lerga M, Krstanović F, Matešić MP, Miklić K, Malić S, Mikša L, Pajcur M, Peruč D, Schubert M, Bertoglio F, Arapović J, Protić A, Šustić A, Milošević M, Šain LČ, Jonjić S, Lisnić VJ, Brizić I. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study. Viruses 2022;14:1966. [PMID: 36146773 DOI: 10.3390/v14091966] [Reference Citation Analysis]
16 de Araújo Morais LR, da Silva Gomes GS. Forecasting daily Covid-19 cases in the world with a hybrid ARIMA and neural network model. Appl Soft Comput 2022;126:109315. [PMID: 35854916 DOI: 10.1016/j.asoc.2022.109315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-mohammadi K, St-denis-bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, Mcguinty M, Saginur R, Langlois M, Cooper CL. Cohort profile: S top the Spread Ottawa (SSO) a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination. BMJ Open 2022;12:e062187. [DOI: 10.1136/bmjopen-2022-062187] [Reference Citation Analysis]
18 Sun C, Han Y, Zhang R, Liu S, Wang J, Zhang Y, Chen X, Jiang C, Wang J, Fan X, Wang J. Regulated necrosis in COVID-19: A double-edged sword. Front Immunol 2022;13:917141. [DOI: 10.3389/fimmu.2022.917141] [Reference Citation Analysis]
19 Takakura Y, Takahashi Y. Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation. J Control Release 2022:S0168-3659(22)00543-0. [PMID: 36029894 DOI: 10.1016/j.jconrel.2022.05.063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zhang R, Sun C, Han Y, Huang L, Sheng H, Wang J, Zhang Y, Lai J, Yuan J, Chen X, Jiang C, Wu F, Wang J, Fan X, Wang J. Neutrophil autophagy and NETosis in COVID-19: perspectives. Autophagy 2022;:1-10. [PMID: 35951555 DOI: 10.1080/15548627.2022.2099206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Islamuddin M, Mustfa SA, Ullah SNMN, Omer U, Kato K, Parveen S. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection. Inflammation 2022. [PMID: 35953688 DOI: 10.1007/s10753-022-01651-y] [Reference Citation Analysis]
22 Olaiz G, Bertozzi SM, Juárez-flores A, Borja-aburto VH, Vicuña F, Ascencio-montiel IJ, Gutierrez JP. Evolution of differences in clinical presentation across epidemic waves among suspected COVID-19 cases who received care at the Mexican Social Security Institute (IMSS).. [DOI: 10.21203/rs.3.rs-1879100/v1] [Reference Citation Analysis]
23 Patel H, McArdle A, Seaby E, Levin M, Whittaker E. The immunopathogenesis of SARS-CoV-2 infection in children: diagnostics, treatment and prevention. Clin Transl Immunology 2022;11:e1405. [PMID: 35903804 DOI: 10.1002/cti2.1405] [Reference Citation Analysis]
24 Pandey SK, Mohanta GC, Kumar V, Gupta K. Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection. Vaccines 2022;10:1200. [DOI: 10.3390/vaccines10081200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ng KW, Faulkner N, Finsterbusch K, Wu M, Harvey R, Hussain S, Greco M, Liu Y, Kjaer S, Swanton C, Gandhi S, Beale R, Gamblin SJ, Cherepanov P, McCauley J, Daniels R, Howell M, Arase H, Wack A, Bauer DLV, Kassiotis G. SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies. Sci Transl Med 2022;14:eabn3715. [PMID: 35895836 DOI: 10.1126/scitranslmed.abn3715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Van der Sluis RM, Holm CK, Jakobsen MR. Plasmacytoid dendritic cells during COVID-19: Ally or adversary? Cell Rep 2022;40:111148. [PMID: 35858624 DOI: 10.1016/j.celrep.2022.111148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Buyvalenko UV, Perepelova MA, Zolotareva RA, Belaya ZE, Melnichenko GA. Pituitary and COVID-19: review. Probl Endokrinol (Mosk) 2022;68:14-23. [DOI: 10.14341/probl13108] [Reference Citation Analysis]
28 Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, Wu Y, Behl S, Taylor JJ, Chakraborty R, Johnson AJ, Schiavo DN, Utz JP, Reisenauer JS, Midthun DE, Mullon JJ, Edell ES, Alameh MG, Borish L, Teague WG, Kaplan MH, Weissman D, Kern R, Hu H, Vassallo R, Liu SL, Sun J. Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination. Sci Immunol 2022;:eadd4853. [PMID: 35857583 DOI: 10.1126/sciimmunol.add4853] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 20.0] [Reference Citation Analysis]
29 Li L, Sullivan A, Musah A, Stavrianaki K, Wood CE, Baker P, Kostkova P. To Zoom or not to Zoom: A longitudinal study of UK population’s activities during the COVID-19 pandemic. PLoS ONE 2022;17:e0270207. [DOI: 10.1371/journal.pone.0270207] [Reference Citation Analysis]
30 Muraille E, Naccache P, Pillot J. The Tragedy of Liberal Democratic Governance in the Face of Global Threats. Front Public Health 2022;10:902724. [DOI: 10.3389/fpubh.2022.902724] [Reference Citation Analysis]
31 Athale J, Gallagher J, Busch LM. Management of Severe and Critical COVID-19 Infection with Immunotherapies. Infectious Disease Clinics of North America 2022. [DOI: 10.1016/j.idc.2022.07.002] [Reference Citation Analysis]
32 Qi H, Liu B, Wang X, Zhang L. The humoral response and antibodies against SARS-CoV-2 infection. Nat Immunol 2022;23:1008-20. [PMID: 35761083 DOI: 10.1038/s41590-022-01248-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
33 Chiale C, Greene TT, Zuniga EI. Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection. Immunol Rev 2022. [PMID: 35775361 DOI: 10.1111/imr.13113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
34 Bucher F, Dastagir K, Obed D, Dieck T, Vogt P. Sustained high demand for intensive care unit resources for the treatment of burn patients during the COVID-19 pandemic in Northern Germany: A single-centre cross-sectional study. JPRAS Open 2022. [DOI: 10.1016/j.jpra.2022.07.002] [Reference Citation Analysis]
35 Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study. Front Immunol 2022;13:918896. [PMID: 35757764 DOI: 10.3389/fimmu.2022.918896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, Brewinska-Olchowik M, Maliszewska A, Sklinda K, Durlik M, Wierzba W, Cossarizza A, Piwocka K. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front Immunol 2022;13:886431. [PMID: 35757700 DOI: 10.3389/fimmu.2022.886431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
37 Park S, Lee K, Im J, Kim J. The Need for Smart Architecture Caused by the Impact of COVID-19 upon Architecture and City: A Systematic Literature Review. Sustainability 2022;14:7900. [DOI: 10.3390/su14137900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Tan SYX, Zhang J, Tee WW. Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer. Front Cell Dev Biol 2022;10:931493. [PMID: 35757000 DOI: 10.3389/fcell.2022.931493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Valanparambil RM, Carlisle J, Linderman SL, Akthar A, Millett RL, Lai L, Chang A, McCook-Veal AA, Switchenko J, Nasti TH, Saini M, Wieland A, Manning KE, Ellis M, Moore KM, Foster SL, Floyd K, Davis-Gardner ME, Edara VV, Patel M, Steur C, Nooka AK, Green F, Johns MA, O'Brein F, Shanmugasundaram U, Zarnitsyna VI, Ahmed H, Nyhoff LE, Mantus G, Garett M, Edupuganti S, Behra M, Antia R, Wrammert J, Suthar MS, Dhodapkar MV, Ramalingam S, Ahmed R. Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant. J Clin Oncol 2022;:JCO2102986. [PMID: 35759727 DOI: 10.1200/JCO.21.02986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Bruiners N, Guerrini V, Ukey R, Dikdan RJ, Yang JH, Mishra PK, Onyuka A, Handler D, Vieth J, Carayannopoulos M, Guo S, Pollen M, Pinter A, Tyagi S, Feingold D, Philipp C, Libutti SK, Gennaro ML. Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report. Front Med 2022;9:915367. [DOI: 10.3389/fmed.2022.915367] [Reference Citation Analysis]
41 Peterson CJ, Lee B, Nugent K. COVID-19 Vaccination Hesitancy among Healthcare Workers-A Review. Vaccines (Basel) 2022;10:948. [PMID: 35746556 DOI: 10.3390/vaccines10060948] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
42 Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-hammarström Q, Abolhassani H, Bompoil T, Dorgham K, Gorochov G, Laouenan C, Rodríguez-gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-picado J, Ozcelik T, Keles S, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang S, Puel A, Wilson MR, Trouillet-assant S, Abel L, Jouanguy E, Ye CJ, Cobat A, Thompson LM, Andreakos E, Zhang Q, Anderson MS, Casanova J, Derisi JL, Abel L, Achille C, Aiuti A, Al-muhsen S, Al-mulla F, Anderson MS, Andreakos E, Angelini M, Arias AA, Aytekin G, Baldanti F, Feldman HB, Belot A, Bergami F, Biggs CM, Bogunovic D, Bolze A, Bondarenko A, Bousfiha AA, Brodin P, Bryceson Y, Bustamante CD, Butte MJ, Casari G, Christodoulou J, Condino-neto A, Constantinescu SN, Conti F, Cooper MA, Dalgard CL, Desai M, Drolet BA, El Baghdadi J, Ergun R, Ergun D, Espinosa-padilla S, Fellay J, Flores C, Franco JL, Froidure A, Ghirardello S, Gregersen PK, Grimbacher B, Haerynck F, Hagin D, Halwani R, Hammarström L, Heath JR, Henrickson SE, Hsieh EW, Husebye E, Imai K, Itan Y, Jarvis ED, Kanat F, Karamitros T, Kisand K, Kopcha V, Korda M, Ku C, Lau Y, Ling Y, Lucas CL, Maniatis T, Mansouri D, Maródi L, Meyts I, Milner JD, Mironska K, Mogensen TH, Mojoli F, Morandeira F, Morio T, Ng LF, Notarangelo LD, Novelli A, Novelli G, O'farrelly C, Okada S, Okamoto K, Ozcelik T, Pagani M, Pan-hammarström Q, Pape JW, de Diego RP, Perlin DS, Pesole G, Pession A, Piralla A, Planas AM, Prando C, Pujol A, Quintana-murci L, Ramaswamy S, Renia L, Resnick I, Rigo-bonnin R, Rodríguez-gallego C, Sancho-shimizu V, Sediva A, Seppänen MR, Shahrooei M, Shcherbina A, Slaby O, Snow AL, Soler-palacín P, Spaan AN, Tancevski I, Tangye SG, Abou Tayoun A, Tulek B, Turvey SE, Uddin KMF, Uddin M, Clément B, Abe-jones Y, Asthana S, Bhide S, Calfee CS, Carrillo SA, Chak S, Collins Z, Erle DJ, Fragiadakis GK, Ghale R, Hendrickson CM, Jauregui A, Kangelaris KN, Krummel MF, Langelier CR, Lea T, Lee D, Leligdowicz A, Leroux C, Lota R, Matthay M, Nguyen V, Patel R, Pierce L, Prasad P, Rao AA, Rashid A, Rodriguez N, Samad B, Shaw C, Sigman A, Tang K, Altamirano LT, Ward A, Willmore A, Wilson M, Woodruff PG, Abel L, Allavena C, Andrejak C, Angoulvant F, Azoulay C, Bachelet D, Bartoli M, Basmaci R, Behilill S, Beluze M, Benech N, Benkerrou D, Bhavsar K, Bitker L, Bouadma L, Bouscambert M, Paz PC, Cervantes-gonzalez M, Chair A, Chirouze C, Coelho A, Cordel H, Couffignal C, Couffin-cadiergues S, d’Ortenzio E, De Montmollin E, Debard A, Debray M, Deplanque D, Descamps D, Desvallée M, Diallo A, Diehl J, Diouf A, Dorival C, Dubos F, Duval X, Eloy P, Enouf V, Epaulard O, Esperou H, Esposito-farese M, Etienne M, Garot D, Gault N, Gaymard A, Ghosn J, Gigante T, Gilg M, Goehringer F, Guedj J, Hoctin A, Hoffmann I, Houas I, Hulot J, Jaafoura S, Kafif O, Kaguelidou F, Kali S, Kerroumi Y, Khalil A, Khan C, Kimmoun A, Laine F, Laouénan C, Laribi S, Le M, Le Bris C, Le Gac S, Le Hingrat Q, Le Mestre S, Le Nagard H, Lemaignen A, Lemee V, Lescure F, Letrou S, Levy Y, Lina B, Lingas G, Lucet JC, Machado M, Malvy D, Mambert M, Manuel A, Mentré F, Meziane A, Mouquet H, Mullaert J, Neant N, Nguyen D, Noret M, Papadopoulos A, Paul C, Peiffer-smadja N, Peigne V, Petrov-sanchez V, Peytavin G, Pham H, Picone O, Piquard V, Poissy J, Puéchal O, Rosa-calatrava M, Rossignol B, Rossignol P, Roy C, Schneider M, Su R, Tardivon C, Tellier M, Téoulé F, Terrier O, Timsit J, Tual C, Tubiana S, Van Der Werf S, Vanel N, Veislinger A, Visseaux B, Wiedemann A, Yazdanpanah Y; COVID HGE consortium, French COVID study group, COMET consortium. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol . [DOI: 10.1126/sciimmunol.abp8966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
43 Ssemaganda A, Nguyen HM, Nuhu F, Jahan N, Card CM, Kiazyk S, Severini G, Keynan Y, Su RC, Ji H, Abrenica B, McLaren PJ, Ball TB, Bullard J, Van Caeseele P, Stein D, McKinnon LR. Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat Commun 2022;13:3357. [PMID: 35688805 DOI: 10.1038/s41467-022-30913-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
44 Makati AC, Ananda AN, Putri JA, Amellia SF, Setiawan B. Molecular docking of ethanol extracts of katuk leaf (Sauropus androgynus) on functional proteins of severe acute respiratory syndrome coronavirus 2. S Afr J Bot 2022;149:1-5. [PMID: 35668920 DOI: 10.1016/j.sajb.2022.04.044] [Reference Citation Analysis]
45 Sedaghat F, Vadvala HV, Shan A, McMahon MT, Gawande RS. Incidence of Contrast-Associated Acute Kidney Injury in Renal-Competent COVID-19 Patients Undergoing Computed Chest Angiography. J Comput Assist Tomogr 2022. [PMID: 35675687 DOI: 10.1097/RCT.0000000000001337] [Reference Citation Analysis]
46 Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, Mathew D, Pattekar A, Reynaldi A, Khoury DS, Gouma S, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Kc W, Oldridge DA, Erickson RI, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, Drapeau EM, Davenport MP, Hensley SE, Bates P, Greenplate AR, Wherry EJ. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell 2022;185:1875-1887.e8. [PMID: 35523182 DOI: 10.1016/j.cell.2022.04.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 28.0] [Reference Citation Analysis]
47 Silva J, Patricio F, Patricio-Martínez A, Santos-López G, Cedillo L, Tizabi Y, Limón ID. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease. Front Neurosci 2022;16:867825. [PMID: 35592266 DOI: 10.3389/fnins.2022.867825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Jahn S, Diamanti E, Herbst M. Immunologie Update für Dermatologen – woran wird geforscht? Aktuelle Dermatologie 2022;48:209-17. [DOI: 10.1055/a-1773-9174] [Reference Citation Analysis]
49 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
50 Jankauskaite L, Malinauskas M, Mickeviciute G. HMGB1: A Potential Target of Nervus Vagus Stimulation in Pediatric SARS-CoV-2-Induced ALI/ARDS. Front Pediatr 2022;10:884539. [DOI: 10.3389/fped.2022.884539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Mencoboni M, Fontana V, Damiani A, Spitaleri A, Raso A, Bottaro LC, Rossi G, Canobbio L, La Camera A, Filiberti RA, Taveggia P, Cavo A. Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology 2022;29:3364-74. [DOI: 10.3390/curroncol29050273] [Reference Citation Analysis]
52 Teng S, Jiang N, Khong KW. Using big data to understand the online ecology of COVID-19 vaccination hesitancy. Humanit Soc Sci Commun 2022;9. [DOI: 10.1057/s41599-022-01185-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Macdougall M, El-hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol 2022;13:871276. [DOI: 10.3389/fimmu.2022.871276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Muena NA, García-Salum T, Pardo-Roa C, Avendaño MJ, Serrano EF, Levican J, Almonacid LI, Valenzuela G, Poblete E, Strohmeier S, Salinas E, Muñoz A, Haslwanter D, Dieterle ME, Jangra RK, Chandran K, González C, Riquelme A, Krammer F, Tischler ND, Medina RA. Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals. EBioMedicine 2022;78:103972. [PMID: 35366624 DOI: 10.1016/j.ebiom.2022.103972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
55 Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles JR, Wu JE, Chen Z, Huang YJ, Belman J, Pattekar A, Manne S, Kuthuru O, Dougherty J, Weiderhold B, Weisman AR, Ittner CAG, Gouma S, Dunbar D, Frank I, Huang AC, Vella LA, Reilly JP, Hensley SE, Rauova L, Zhao L, Meyer NJ, Poncz M, Abrams CS, Wherry EJ; UPenn COVID Processing Unit. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19. Front Immunol 2022;13:834988. [PMID: 35309299 DOI: 10.3389/fimmu.2022.834988] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
57 Shivshankar P, Karmouty-Quintana H, Mills T, Doursout MF, Wang Y, Czopik AK, Evans SE, Eltzschig HK, Yuan X. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets. Inflammation 2022. [PMID: 35320469 DOI: 10.1007/s10753-022-01656-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
58 Symeonaki E, Arvanitis KG, Piromalis D, Tseles D, Balafoutis AT. Ontology-Based IoT Middleware Approach for Smart Livestock Farming toward Agriculture 4.0: A Case Study for Controlling Thermal Environment in a Pig Facility. Agronomy 2022;12:750. [DOI: 10.3390/agronomy12030750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lederer K, Bettini E, Parvathaneni K, Painter MM, Agarwal D, Lundgreen KA, Weirick M, Muralidharan K, Castaño D, Goel RR, Xu X, Drapeau EM, Gouma S, Ort JT, Awofolaju M, Greenplate AR, Le Coz C, Romberg N, Trofe-Clark J, Malat G, Jones L, Rosen M, Weiskopf D, Sette A, Besharatian B, Kaminiski M, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 2022;185:1008-1024.e15. [PMID: 35202565 DOI: 10.1016/j.cell.2022.01.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 26.0] [Reference Citation Analysis]
60 Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Jain SK, Bivalacqua TJ, Yegnasubramanian S, Bishai WR. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation. bioRxiv 2022:2022. [PMID: 35313583 DOI: 10.1101/2022.03.15.484018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Zare M, Mirahmadizadeh A, Akbari M, Moradian MJ. Comparison of in-hospital mortality of COVID-19 between pregnant and non-pregnant women infected with SARS-CoV-2; a historical cohort study. Journal of Perinatal Medicine 2022;0. [DOI: 10.1515/jpm-2022-0056] [Reference Citation Analysis]
62 Herzog SA, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H. Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020. Euro Surveill 2022;27. [PMID: 35241216 DOI: 10.2807/1560-7917.ES.2022.27.9.2100419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sharma M, Vanam HP, Panda NK, Patro SK, Arora R, Bhadada SK, Rudramurthy SM, Singh MP, Koppula PR. Deciphering the Neurosensory Olfactory Pathway and Associated Neo-Immunometabolic Vulnerabilities Implicated in COVID-Associated Mucormycosis (CAM) and COVID-19 in a Diabetes Backdrop—A Novel Perspective. Diabetology 2022;3:193-235. [DOI: 10.3390/diabetology3010013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Hamed AA, Fandy TE, Tkaczuk KL, Verspoor K, Lee BS. COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments. Pharmaceutics 2022;14:567. [DOI: 10.3390/pharmaceutics14030567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Fuentes-Villalobos F, Garrido JL, Medina MA, Zambrano N, Ross N, Bravo F, Gaete-Argel A, Oyarzún-Arrau A, Amanat F, Soto-Rifo R, Valiente-Echeverría F, Ocampo R, Esveile C, Ferreira L, Cabrera J, Torres V, Rioseco ML, Riquelme R, Barría S, Alvarez R, Pinos Y, Krammer F, Calvo M, Barria MI; COVID-19 South Chile Group. Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence. Front Immunol 2022;13:796481. [PMID: 35197972 DOI: 10.3389/fimmu.2022.796481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
66 Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, Mathew D, Pattekar A, Reynaldi A, Khoury DS, Gouma S, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Kc W, Oldridge DA, Erickson RI, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, Drapeau EM, Davenport MP, Hensley SE, Bates P, Greenplate AR, Wherry EJ. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. bioRxiv 2022:2022. [PMID: 35233575 DOI: 10.1101/2022.02.20.481163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
67 Cillóniz C, Pericàs JM, Rojas JR, Torres A. Severe Infections Due to Respiratory Viruses. Semin Respir Crit Care Med 2022;43:60-74. [PMID: 35172359 DOI: 10.1055/s-0041-1740982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:107602962110566. [DOI: 10.1177/10760296211056648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Puchinger K, Castelletti N, Rubio-acero R, Geldmacher C, Eser TM, Deák F, Paunovic I, Bakuli A, Saathoff E, von Meyer A, Markgraf A, Falk P, Reich J, Riess F, Girl P, Müller K, Radon K, Guggenbuehl Noller JM, Wölfel R, Hoelscher M, Kroidl I, Wieser A, Olbrich L, Alamoudi E, Anderson J, Baumann M, Behlen M, Beyerl J, Böhnlein R, Brauer A, Britz V, Bruger J, Caroli F, Contento L, Diekmannshemke J, Do A, Dobler G, Eberle U, Eckstein J, Frese J, Forster F, Frahnow T, Fröschl G, Geisenberger O, Gillig K, Heiber A, Hinske C, Hoefflin J, Hofberger T, Höfinger M, Hofmann L, Horn S, Huber K, Janke C, Kappl U, Kiani C, Kroidl A, Laxy M, Leidl R, Lindner F, Mayrhofer R, Mekota A, Müller H, Metaxa D, Pattard L, Pletschette M, Prückner S, Pusl K, Raimúndez E, Rothe C, Schäfer N, Schandelmaier P, Schneider L, Schultz S, Schunk M, Schwettmann L, Seibold H, Sothmann P, Stapor P, Theis F, Thiel V, Thiesbrummel S, Thur N, Waibel J, Wallrauch C, Winter S, Wolff J, Wullinger P, Yaqine H, Zange S, Zeggini E, Zimmermann T, Zielke A, Ibraheem M, Ahmed M, Becker M, Diepers P, Schälte Y, Garí M, Pütz P, Pritsch M, Fingerle V, Le Gleut R, Gilberg L, Brand I, Diefenbach M, Eser T, Weinauer F, Martin S, Quenzel E, Durner J, Girl P, Müller K, Radon K, Fuchs C, Hasenauer J. The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases. Virology 2022. [DOI: 10.1016/j.virol.2022.02.002] [Reference Citation Analysis]
70 Peddireddy SP, Rahman SA, Cillo AR, Vijay GM, Somasundaram A, Workman CJ, Bain W, Mcverry BJ, Methe B, Lee JS, Ray P, Ray A, Bruno TC, Vignali DAA, Kitsios GD, Morris A, Singh H, Sarkar A, Das J. Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19.. [DOI: 10.1101/2022.01.24.477545] [Reference Citation Analysis]
71 Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, Wu Y, Behl S, Taylor JJ, Chakaraborty R, Johnson AJ, Shiavo DN, Utz JP, Reisenauer JS, Midthun DE, Mullon JJ, Edell ES, Alameh MG, Borish L, Kaplan MH, Weissman D, Kern R, Hu H, Vassallo R, Liu S, Sun J. Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination.. [DOI: 10.1101/2022.01.26.22269659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif LJ, Peeples ME, Liu SL. SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci U S A 2022;119:e2111400119. [PMID: 34937699 DOI: 10.1073/pnas.2111400119] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 38.0] [Reference Citation Analysis]
73 Mao T, Israelow B, Lucas C, Vogels CBF, Gomez-Calvo ML, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M, Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A; Yale SARS-CoV-2 Genome Surveillance Initiative. A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice. J Exp Med 2022;219:e20211818. [PMID: 34757384 DOI: 10.1084/jem.20211818] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
74 Antunes KH, de Souza APD. Isolation and Cell Culture of Human Nasopharyngeal Cells: A Model for Testing Immune Response and Antiviral Treatment. Multiplex Biomarker Techniques 2022. [DOI: 10.1007/978-1-0716-2395-4_28] [Reference Citation Analysis]
75 Hannah A, Lowe T. The effect of the SARS-CoV-2 pandemic on suspected cancer referrals at a regional head and neck unit. Advances in Oral and Maxillofacial Surgery 2022;5:100226. [DOI: 10.1016/j.adoms.2021.100226] [Reference Citation Analysis]
76 Lu L, Feng P, Yu M, Chen M, Lin AJ, Chen JL, Yu LH. Current utilization of interferon alpha for the treatment of coronavirus disease 2019: a comprehensive review. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
77 Naghavi S, Kavosh A, Adibi I, Shaygannejad V, Arabi S, Rahimi M, Mazaheri S, Ashtari F. COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021. Mult Scler Relat Disord 2022;57:103335. [PMID: 35158427 DOI: 10.1016/j.msard.2021.103335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bailey SF, Akter M. The Evolution of SARS-CoV-2. Studies to Combat COVID-19 using Science and Engineering 2022. [DOI: 10.1007/978-981-19-1356-3_5] [Reference Citation Analysis]
79 Bastard P, Zhang Q, Zhang S, Jouanguy E, Casanova J. Type I interferons and SARS-CoV-2: from cells to organisms. Current Opinion in Immunology 2022. [DOI: 10.1016/j.coi.2022.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
80 Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. PLoS Pathog 2021;17:e1010106. [PMID: 34969061 DOI: 10.1371/journal.ppat.1010106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
81 Alonzi T, Aiello A, Petrone L, Najafi Fard S, D'Eletto M, Falasca L, Nardacci R, Rossin F, Delogu G, Castilletti C, Capobianchi MR, Ippolito G, Piacentini M, Goletti D. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Cells 2021;11:52. [PMID: 35011614 DOI: 10.3390/cells11010052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Sinclair NRS. Beginnings of coinhibition. Scand J Immunol 2021;94:e13098. [PMID: 34940993 DOI: 10.1111/sji.13098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Sureshchandra S, Lewis SA, Doratt BM, Jankeel A, Coimbra Ibraim I, Messaoudi I. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight 2021;6:e153201. [PMID: 34935643 DOI: 10.1172/jci.insight.153201] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
84 Ai J, Wang J, Liu D, Xiang H, Guo Y, Lv J, Zhang Q, Li J, Zhang X, Li Q, Liang J, Guo X, Feng Y, Liu L, Zhang X, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhang Y, Xie F, Jiang S, Yan Y, Qiu Y, Wu H, Hou Z, Zhang N, Zhang A, Ji J, Yang J, Huang J, Zhao Z, Gu Y, Bian L, Zhang Z, Zou S, Ji H, Ge G, Du X, Hou A, Zhu Y, Cong Q, Xu J, Zu H, Wang Y, Yan Z, Yan X, BianBa Y, Ci Q, Zhang L, Yang S, Gao X, Zhong L, He S, Liu C, Huang Y, Liu Y, Xu D, Zhu Q, Xu X, Lv M, Zhang W, Qi X. Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): A multicenter study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01346-X. [PMID: 34942370 DOI: 10.1016/j.cgh.2021.12.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
85 Colarusso C, Maglio A, Terlizzi M, Vitale C, Molino A, Pinto A, Vatrella A, Sorrentino R. Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β. Biomedicines 2021;9:1931. [PMID: 34944747 DOI: 10.3390/biomedicines9121931] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
86 Roh EH, Fromen CA, Sullivan MO. Inhalable mRNA vaccines for respiratory diseases: a roadmap. Curr Opin Biotechnol 2021;74:104-9. [PMID: 34894574 DOI: 10.1016/j.copbio.2021.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Kleymenov DA, Bykonia EN, Popova LI, Mazunina EP, Gushchin VA, Kolobukhina LV, Burgasova OA, Kruzhkova IS, Kuznetsova NA, Shidlovskaya EV, Divisenko EV, Pochtovyi AA, Bacalin VV, Smetanina SV, Tkachuk AP, Logunov DY, Gintsburg AL. A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels. Front Immunol 2021;12:771609. [PMID: 34858428 DOI: 10.3389/fimmu.2021.771609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
88 Ng KW, Faulkner N, Finsterbusch K, Wu M, Harvey R, Hussain S, Greco M, Liu Y, Kjaer S, Swanton C, Gandhi S, Beale R, Gamblin SJ, Cherepanov P, Mccauley J, Daniels R, Howell M, Arase H, Wack A, Bauer DL, Kassiotis G. Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination.. [DOI: 10.1101/2021.11.30.470568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Oliveira-silva J, Reis T, Lopes C, Batista-silva R, Ribeiro R, Marques G, Pacheco V, Rodrigues T, Afonso A, Pinheiro V, Araújo L, Rodrigues F, Antunes I. Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers. Vaccine 2021. [DOI: 10.1016/j.vaccine.2021.12.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
90 Barnby E, Reynolds M, Gordon J. Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know. NASN Sch Nurse 2022;37:13-8. [PMID: 34836470 DOI: 10.1177/1942602X211044996] [Reference Citation Analysis]
91 Lim PN, Cervantes MM, Pham LK, Rothchild AC. Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Rev Mol Med 2021;23:e18. [PMID: 34823627 DOI: 10.1017/erm.2021.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
92 Cohen P, Degrace EJ, Danziger O, Patel RS, Rosenberg BR. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.. [DOI: 10.1101/2021.11.22.469642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Jacob A, Puskoor S, White HD. Bowel perforation in morbid obesity secondary to COVID-19 infection. Baylor University Medical Center Proceedings 2022;35:202-3. [DOI: 10.1080/08998280.2021.2003099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Salasc F, Lahlali T, Laurent E, Rosa-Calatrava M, Pizzorno A. Treatments for COVID-19: Lessons from 2020 and new therapeutic options. Curr Opin Pharmacol 2021;62:43-59. [PMID: 34915400 DOI: 10.1016/j.coph.2021.11.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
95 Wholey WY, Yoda ST, Cheng W. Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice. Bioconjug Chem 2021. [PMID: 34775749 DOI: 10.1021/acs.bioconjchem.1c00463] [Reference Citation Analysis]
96 Agrawal S, Salazar J, Tran TM, Agrawal A. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2. Front Immunol 2021;12:739757. [PMID: 34745109 DOI: 10.3389/fimmu.2021.739757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Basile MS, Cavalli E, McCubrey J, Hernández-Bello J, Muñoz-Valle JF, Fagone P, Nicoletti F. The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19. Drug Discov Today 2021:S1359-6446(21)00480-3. [PMID: 34763066 DOI: 10.1016/j.drudis.2021.11.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
98 Schneider IK, Dorrough AR, Frank C. Ambivalence and Self-Reported Adherence to Recommendations to Reduce the Spread of COVID-19. Social Psychology 2021;52:362-74. [DOI: 10.1027/1864-9335/a000465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Lüscher-Dias T, Conceição IM, Schuch V, Maracaja-Coutinho V, Amaral PP, Nakaya HI. Long non-coding RNAs associated with infection and vaccine-induced immunity. Essays Biochem 2021;65:657-69. [PMID: 34528687 DOI: 10.1042/EBC20200072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 van Oosten L, Altenburg JJ, Fougeroux C, Geertsema C, van den End F, Evers WAC, Westphal AH, Lindhoud S, van den Berg W, Swarts DC, Deurhof L, Suhrbier A, Le TT, Torres Morales S, Myeni SK, Kikkert M, Sander AF, de Jongh WA, Dagil R, Nielsen MA, Salanti A, Søgaard M, Keijzer TMP, Weijers D, Eppink MHM, Wijffels RH, van Oers MM, Martens DE, Pijlman GP. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. mBio 2021;12:e0181321. [PMID: 34634927 DOI: 10.1128/mBio.01813-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
101 Fraietta R, de Carvalho RC, Camillo J, Groner MF, Truzzi JCCI, Petkov CN, Barradas V, Homsi C, Bellei N, Oehninger S. SARS-CoV-2 is not found in human semen during mild COVID-19 acute stage. Andrologia 2021;:e14286. [PMID: 34693544 DOI: 10.1111/and.14286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Eddins DJ, Bassit L, Chandler JD, Haddad NS, Musall KL, Yang J, Kosters A, Dobosh BS, Hernández MR, Ramonell RP, Tirouvanziam RM, Lee FE, Zandi K, Schinazi RF, Ghosn EE. Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies.. [DOI: 10.1101/2021.10.22.465481] [Reference Citation Analysis]
103 Sfikakis PP, Verrou KM, Ampatziadis-Michailidis G, Tsitsilonis O, Paraskevis D, Kastritis E, Lianidou E, Moutsatsou P, Terpos E, Trougakos I, Chini V, Manoloukos M, Moulos P, Pavlopoulos GA, Kollias G, Hatzis P, Dimopoulos MA. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection. Front Immunol 2021;12:746203. [PMID: 34675930 DOI: 10.3389/fimmu.2021.746203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
104 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochem Pharmacol 2021;193:114809. [PMID: 34673016 DOI: 10.1016/j.bcp.2021.114809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
105 Niessl J, Sekine T, Buggert M. T cell immunity to SARS-CoV-2. Semin Immunol 2021;:101505. [PMID: 34711489 DOI: 10.1016/j.smim.2021.101505] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
106 Zhao Z, Feng M, Wan J, Zheng X, Teng C, Xie X, Pan W, Hu B, Huang J, Liu Z, Wu J, Cai S. Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities. Food Funct 2021;12:9607-19. [PMID: 34549212 DOI: 10.1039/d1fo01352a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
107 Dupont L, Snell LB, Graham C, Seow J, Merrick B, Lechmere T, Maguire TJA, Hallett SR, Pickering S, Charalampous T, Alcolea-Medina A, Huettner I, Jimenez-Guardeño JM, Acors S, Almeida N, Cox D, Dickenson RE, Galao RP, Kouphou N, Lista MJ, Ortega-Prieto AM, Wilson H, Winstone H, Fairhead C, Su JZ, Nebbia G, Batra R, Neil S, Shankar-Hari M, Edgeworth JD, Malim MH, Doores KJ. Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern. Nat Microbiol 2021;6:1433-42. [PMID: 34654917 DOI: 10.1038/s41564-021-00974-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 50.0] [Reference Citation Analysis]
108 Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Baxter AE, Oldridge DA, Giles JR, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Drapeau EM, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, Frank I, Betts MR, Vella LA, Grifoni A, Weiskopf D, Sette A, Hensley SE, Davenport MP, Bates P, Luning Prak ET, Greenplate AR, Wherry EJ, Adamski S, Alam Z, Addison MM, Byrne KT, Chandra A, Descamps HC, Han N, Kaminskiy Y, Kammerman SC, Kim J, Greenplate AR, Hamilton JT, Markosyan N, Noll JH, Omran DK, Pattekar A, Perkey E, Prager EM, Pueschl D, Rennels A, Shah JB, Shilan JS, Wilhausen N, Vanderbeck AN; UPenn COVID Processing Unit‡. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 2021;:eabm0829. [PMID: 34648302 DOI: 10.1126/science.abm0829] [Cited by in Crossref: 262] [Cited by in F6Publishing: 254] [Article Influence: 262.0] [Reference Citation Analysis]
109 Chu C, Baxamusa S, Witherel C. Impact of COVID-19 on materials science research innovation and related pandemic response. MRS Bull 2021;:1-6. [PMID: 34658504 DOI: 10.1557/s43577-021-00186-1] [Reference Citation Analysis]
110 Vályi-Nagy I, Matula Z, Gönczi M, Tasnády S, Bekő G, Réti M, Ajzner É, Uher F. Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans. Geroscience 2021;43:2321-31. [PMID: 34633612 DOI: 10.1007/s11357-021-00471-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
111 Russo G, Di Salvatore V, Sgroi G, Parasiliti Palumbo GA, Reche PA, Pappalardo F. A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets. Brief Bioinform 2021:bbab403. [PMID: 34607353 DOI: 10.1093/bib/bbab403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
112 Upadhyay AA, Hoang TN, Pino M, Boddapati AK, Viox EG, Lee MYH, Corry J, Strongin Z, Cowan DA, Beagle EN, Horton TR, Hamilton S, Aoued H, Harper JL, Nguyen K, Pellegrini KL, Tharp GK, Piantadosi A, Levit RD, Amara RR, Barratt-Boyes SM, Ribeiro SP, Sekaly RP, Vanderford TH, Schinazi RF, Paiardini M, Bosinger SE. TREM2+ and interstitial macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques. bioRxiv 2021:2021. [PMID: 34642693 DOI: 10.1101/2021.10.05.463212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 Chifu I, Detomas M, Dischinger U, Kimpel O, Megerle F, Hahner S, Fassnacht M, Altieri B. Management of Patients With Glucocorticoid-Related Diseases and COVID-19. Front Endocrinol (Lausanne) 2021;12:705214. [PMID: 34594302 DOI: 10.3389/fendo.2021.705214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
114 Takakura Y. Activities of the Pharmaceutical Society of Japan: Collaboration With Science Council of Japan. tits 2021;26:10_72-10_77. [DOI: 10.5363/tits.26.10_72] [Reference Citation Analysis]
115 Anderson EM, Eilola T, Goodwin E, Bolton MJ, Gouma S, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, Brock A, Weaver J, Millar JS, Derohannessian S, Greenplate AR, Frank I, Rader DJ, Wherry EJ, Hensley SE, The UPenn COVID Processing Unit. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations.. [DOI: 10.1101/2021.09.30.21264363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
116 Lederer K, Parvathaneni K, Painter MM, Bettini E, Agarwal D, Lundgreen KA, Weirick M, Goel RR, Xu X, Drapeau EM, Gouma S, Greenplate AR, Coz CL, Romberg N, Jones L, Rosen M, Besharatian B, Kaminiski M, Weiskopf D, Sette A, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv 2021:2021. [PMID: 34580676 DOI: 10.1101/2021.09.16.21263686] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
117 Shoukry NH. Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV. Viruses 2021;13:1871. [PMID: 34578451 DOI: 10.3390/v13091871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
118 Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, Fera D, Shafer RW. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet 2021. [PMID: 34535792 DOI: 10.1038/s41576-021-00408-x] [Cited by in Crossref: 373] [Cited by in F6Publishing: 393] [Article Influence: 373.0] [Reference Citation Analysis]
119 Zanoni I. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? Curr Opin Virol 2021;50:119-27. [PMID: 34454352 DOI: 10.1016/j.coviro.2021.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
120 Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Baxter AE, Oldridge DA, Giles JR, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Drapeau EM, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, Frank I, Betts MR, Vella LA, Grifoni A, Weiskopf D, Sette A, Hensley SE, Davenport MP, Bates P, Luning Prak ET, Greenplate AR, Wherry EJ; UPenn COVID Processing Unit. mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. bioRxiv 2021:2021. [PMID: 34462751 DOI: 10.1101/2021.08.23.457229] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 34.0] [Reference Citation Analysis]
121 Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cells 2021;10:2134. [PMID: 34440903 DOI: 10.3390/cells10082134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
122 Subramani J, Shaabani N, Shetty D, Wu H, Kwon S, Li W, Yue C, Lahtz C, Ramirez-torres A, Zhou H, Zhang Y, Allen R, Farley B, Emalfarb M, Tchelet R, Markku S, Marika V, Wiebe M, Huuskonen A, Ben-artzi H, Avigdor A, Ji H, Herrmann A. Protein-based RBD-C-tag COVID-19 Vaccination Candidate Elicits Protection Activity against SARS-COV-2 Variant Infection.. [DOI: 10.1101/2021.08.17.456704] [Reference Citation Analysis]
123 Escaffre O, Freiberg AN. Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells. Antiviral Res 2021;194:105162. [PMID: 34384825 DOI: 10.1016/j.antiviral.2021.105162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med 2021;218:e20211211. [PMID: 34357402 DOI: 10.1084/jem.20211211] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 41.0] [Reference Citation Analysis]
125 Alenquer M, Ferreira F, Lousa D, Valério M, Medina-Lopes M, Bergman ML, Gonçalves J, Demengeot J, Leite RB, Lilue J, Ning Z, Penha-Gonçalves C, Soares H, Soares CM, Amorim MJ. Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies. PLoS Pathog 2021;17:e1009772. [PMID: 34352039 DOI: 10.1371/journal.ppat.1009772] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 42.0] [Reference Citation Analysis]
126 Carlton LH, Chen T, Whitcombe AL, McGregor R, Scheurich G, Sheen CR, Dickson JM, Bullen C, Chiang A, Exeter DJ, Paynter J, Baker MG, Charlewood R, Moreland NJ. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand. Epidemiol Infect 2021;149:e173. [PMID: 34668464 DOI: 10.1017/S0950268821001643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
127 Şentürk M, El Tahan MR, Shelley B, Szegedi LL, Piccioni F, Licker MJ, Karzai W, Gil MG, Neskovic V, Vanpeteghem C, Pelosi P, Cohen E, Sorbello M, MBChB JB, Stoica R, Mourisse J, Brunelli A, Jimenez MJ, Drnvsek-Globoikar M, Yapici D, Morsy AS, Kawagoe I, Végh T, Navarro-Ripoll R, Marczin N, Paloczi B, Unzueta C, Gregorio GD, Wouters P, Rex S, Mukherjee C, Paternoster G, Guarracino F. Thoracic Anesthesia during the COVID-19 Pandemic: 2021 Updated Recommendations by the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) Thoracic Subspecialty Committee. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00608-X. [PMID: 34479782 DOI: 10.1053/j.jvca.2021.07.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
128 Marx V. Scientists set out to connect the dots on long COVID. Nat Methods 2021;18:449-53. [PMID: 33911230 DOI: 10.1038/s41592-021-01145-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
129 Madany E, Okwan-Duodu D, Balbuena-Merle R, Hendrickson JE, Gibb DR. Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease. Front Med (Lausanne) 2021;8:679030. [PMID: 34368185 DOI: 10.3389/fmed.2021.679030] [Reference Citation Analysis]
130 Gallichotte EN, Nehring M, Young MC, Pugh S, Sexton NR, Fitzmeyer E, Quicke KM, Richardson M, Pabilonia KL, Ehrhart N, Fosdick BK, VandeWoude S, Ebel GD. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks. Microbiol Spectr 2021;9:e0022421. [PMID: 34287058 DOI: 10.1128/Spectrum.00224-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
131 Wang R, Lee JH, Xiong F, Kim J, Hasani LA, Yuan X, Shivshankar P, Krakowiak J, Qi C, Wang Y, Eltzschig HK, Li W. SARS-CoV-2 Restructures the Host Chromatin Architecture. bioRxiv 2021:2021. [PMID: 34312624 DOI: 10.1101/2021.07.20.453146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
132 Lucia-sanz A, Magalie A, Rodriguez-gonzalez R, Leung C, Weitz JS. Modeling shield immunity to reduce COVID-19 transmission in long-term care facilities.. [DOI: 10.1101/2021.07.16.21260657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Cotsapas C, Saarela J, Farmer JR, Scaria V, Abraham RS. Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? J Clin Invest 2021;131:149459. [PMID: 34061775 DOI: 10.1172/JCI149459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Almeida-da-Silva CLC, Matshik Dakafay H, Liu K, Ojcius DM. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells. Int J Mol Sci 2021;22:7669. [PMID: 34299289 DOI: 10.3390/ijms22147669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
135 Sureshchandra S, Lewis SA, Doratt B, Jankeel A, Ibraim I, Messaoudi I. Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine.. [DOI: 10.1101/2021.07.14.452381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
136 Cardinale M. Preparing athletes and staff for the first "pandemic" Olympic Games. J Sports Med Phys Fitness 2021;61:1052-60. [PMID: 34256538 DOI: 10.23736/S0022-4707.21.12745-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Speciale AC. Commentary: Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2. Front Public Health 2021;9:702199. [PMID: 34327188 DOI: 10.3389/fpubh.2021.702199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
138 Vogel F, Reincke M. Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 2021. [PMID: 34241765 DOI: 10.1007/s11154-021-09670-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
139 Shin EC. Scientific Understanding of COVID-19: The First Step to Vanquishing the Current Pandemic. Mol Cells 2021;44:375-6. [PMID: 34187968 DOI: 10.14348/molcells.2021.0146] [Reference Citation Analysis]
140 Fonseca C, Costa A, Esteves M, de Carvalho B, Souza C, Teixeira C, Araujo da Silva A. Indirect impact on number of admitted children with COVID-19 in the first three months of emergency use of two vaccines, in Rio de Janeiro, Brazil.. [DOI: 10.1101/2021.07.01.21259330] [Reference Citation Analysis]
141 Niesen MJ, Anand P, Silvert E, Suratekar R, Pawlowski C, Ghosh P, Lenehan P, Hughes T, Zemmour D, O’horo JC, Yao JD, Pritt BS, Norgan A, Hurt RT, Badley AD, Venkatakrishnan A, Soundararajan V. COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance.. [DOI: 10.1101/2021.07.01.21259833] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
142 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 38.0] [Reference Citation Analysis]
143 Al-Sanafi M, Sallam M. Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales. Vaccines (Basel) 2021;9:701. [PMID: 34202298 DOI: 10.3390/vaccines9070701] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 45.0] [Reference Citation Analysis]
144 Messmer M, Wagner-Johnston N. COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers. Leuk Lymphoma 2021;62:3019-22. [PMID: 34151698 DOI: 10.1080/10428194.2021.1941939] [Reference Citation Analysis]
145 Cossart P. The corona virus SARS-CoV-2 and the pandemic Covid19. C R Biol 2021;344:1-5. [PMID: 34213844 DOI: 10.5802/crbiol.51] [Reference Citation Analysis]
146 Sachdev S, Pathak S, Sharma RR, Mahapatra M. Convalescent Plasma the Old Warhorse First to be Inducted in Pandemics is not the Zippy Chippy of Derby. Indian J Hematol Blood Transfus 2021;:1-2. [PMID: 34177140 DOI: 10.1007/s12288-021-01457-2] [Reference Citation Analysis]
147 Björkström NK, Ponzetta A. Natural killer cells and unconventional T cells in COVID-19. Curr Opin Virol 2021;49:176-82. [PMID: 34217135 DOI: 10.1016/j.coviro.2021.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
148 Mao T, Israelow B, Lucas C, Vogels CBF, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M, Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A; Yale SARS-CoV-2 Genome Surveillance Initiative. A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice. bioRxiv 2021:2021. [PMID: 34159330 DOI: 10.1101/2021.06.16.448754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
149 Talla A, Vasaikar SV, Lemos MP, Moodie Z, Pebworth ML, Henderson KE, Cohen KW, Czartoski JL, Lai L, Suthar MS, Heubeck AT, Genge PC, Roll CR, Weiss M, Reading J, Kondza N, MacMillan H, Fong OC, Thomson ZJ, Graybuck LT, Newell EW, Coffey EM, Meijer P, Becker LA, De Rosa SC, Torgerson TR, Skene PJ, Li X, Szeto GL, McElrath MJ, Bumol TF. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv 2021:2021. [PMID: 34075380 DOI: 10.1101/2021.05.26.442666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
150 Dupont L, Snell LB, Graham C, Seow J, Merrick B, Lechmere T, Hallett SR, Charalampous T, Alcolea-Medina A, Huettner I, Maguire TJA, Acors S, Almeida N, Cox D, Dickenson RE, Galao RP, Jimenez-Guardeño JM, Kouphou N, Lista MJ, Pickering S, Ortega-Prieto AM, Wilson H, Winstone H, Fairhead C, Su J, Nebbia G, Batra R, Neil S, Shankar-Hari M, Edgeworth JD, Malim MH, Doores KJ. Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections. medRxiv 2021:2021. [PMID: 34127977 DOI: 10.1101/2021.06.07.21258351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
151 Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H, Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F; Personalized Virology Initiative. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 2021;184:3936-3948.e10. [PMID: 34192529 DOI: 10.1016/j.cell.2021.06.005] [Cited by in Crossref: 145] [Cited by in F6Publishing: 154] [Article Influence: 145.0] [Reference Citation Analysis]
152 Eddins DJ, Yang J, Kosters A, Giacalone VD, Pechuan X, Chandler JD, Eum J, Babcock BR, Dobosh BS, Hernández MR, Abdulkhader F, Collins GL, Ramonell RP, Moussion C, Orlova DY, Sanz I, Lee FE, Tirouvanziam RM, Ghosn EE. Pathogenic neutrophilia drives acute respiratory distress syndrome in severe COVID-19 patients.. [DOI: 10.1101/2021.06.02.446468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Phetsouphanh C, Darley D, Wilson DB, Howe A, Ling Munier CM, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, Kelleher AD, Matthews GV. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection.. [DOI: 10.1101/2021.06.01.21257759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
154 Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, Singh M, Lievano F, Tafur A, Ramacciotti E, Gerotziafas GT, Jeske W, Fareed J. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost 2021;27:10760296211021498. [PMID: 34060379 DOI: 10.1177/10760296211021498] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
155 Zeng C, Evans JP, King T, Zheng YM, Oltz EM, Whelan SPJ, Saif L, Peeples ME, Liu SL. SARS-CoV-2 Spreads through Cell-to-Cell Transmission. bioRxiv 2021:2021. [PMID: 34100011 DOI: 10.1101/2021.06.01.446579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
156 Nagaraja S, Jain D, Kesavardhana S. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats. J Leukoc Biol 2021. [PMID: 34057760 DOI: 10.1002/JLB.4COVHR0221-093RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
157 Pirovano G, Ordonez AA, Jain SK, Reiner T, Carroll LS, Pillarsetty NVK. Rapid detection of SARS-CoV-2 using a radiolabeled antibody. Nucl Med Biol 2021;98-99:69-75. [PMID: 34058614 DOI: 10.1016/j.nucmedbio.2021.05.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Roman M, Grudzień P. The Essence of Agritourism and Its Profitability during the Coronavirus (COVID-19) Pandemic. Agriculture 2021;11:458. [DOI: 10.3390/agriculture11050458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
159 Wack A. Monocyte and dendritic cell defects in COVID-19. Nat Cell Biol 2021;23:445-7. [PMID: 33972732 DOI: 10.1038/s41556-021-00685-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
160 Lu Y, Han K, Xue G, Zheng N, Jin G. Estimated Spike Evolution and Impact of Emerging SARS-CoV-2 Variants.. [DOI: 10.1101/2021.05.06.21256705] [Reference Citation Analysis]
161 Ssemaganda A, Nguyen HM, Nuhu F, Jahan N, Card CM, Kiazyk S, Severini G, Keynan Y, Su R, Ji H, Abrenica B, Mclaren PJ, Ball TB, Bullard J, Van Caeseele P, Stein D, Mckinnon LR. Expansion of tissue-resident CD8+ T cells and CD4+ Th17 cells in the nasal mucosa following mRNA COVID-19 vaccination.. [DOI: 10.1101/2021.05.07.442971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
162 Gallichotte EN, Nehring M, Young MC, Pugh S, Sexton NR, Fitzmeyer E, Quicke KM, Richardson M, Pabilonia KL, Ehrhart N, Fosdick BK, Vandewoude S, Ebel GD. Durable antibody responses in staff at two long-term care facilities, during and post SARS-CoV-2 outbreaks.. [DOI: 10.1101/2021.05.04.442699] [Reference Citation Analysis]
163 Shirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc 2021;152:514-525.e8. [PMID: 34176567 DOI: 10.1016/j.adaj.2021.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
164 Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles J, Wu JE, Chen Z, Huang YJ, Pattekar A, Manne S, Kuthuru O, Dougherty J, Weiderhold B, Weisman AR, Ittner CAG, Gouma S, Dunbar D, Frank I, Huang AC, Vella LA, Reilly JP, Hensley SE, Rauova L, Zhao L, Meyer NJ, Poncz M, Abrams CS, Wherry EJ; UPenn COVID Processing Unit. Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19. bioRxiv 2021:2021. [PMID: 33972943 DOI: 10.1101/2021.05.01.442279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
165 Amanat F, Thapa M, Lei T, Sayed Ahmed SM, Adelsberg DC, Carreno JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H, Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F; Personalized Virology Initiative. The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD. medRxiv 2021:2021. [PMID: 33758878 DOI: 10.1101/2021.03.07.21253098] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
166 Trahtemberg U, Rottapel R, Dos Santos CC, Slutsky AS, Baker A, Fritzler MJ. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis 2021;80:1236-40. [PMID: 33903092 DOI: 10.1136/annrheumdis-2021-220206] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
167 Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, Gouma S, Hicks P, Meng W, Rosenfeld AM, Dysinger S, Lundgreen KA, Kuri-Cervantes L, Adamski S, Hicks A, Korte S, Oldridge DA, Baxter AE, Giles JR, Weirick ME, McAllister CM, Dougherty J, Long S, D'Andrea K, Hamilton JT, Betts MR, Luning Prak ET, Bates P, Hensley SE, Greenplate AR, Wherry EJ. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Sci Immunol 2021;6:eabi6950. [PMID: 33858945 DOI: 10.1126/sciimmunol.abi6950] [Cited by in Crossref: 361] [Cited by in F6Publishing: 360] [Article Influence: 361.0] [Reference Citation Analysis]
168 Alenquer M, Ferreira F, Lousa D, Valerio M, Medina-lopes M, Bergman M, Goncalves J, Demengeot J, Leite RB, Lilue J, Ning Z, Penha-goncalves C, Soares H, Soares C, Amorim MJ. Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding.. [DOI: 10.1101/2021.04.22.441007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
169 Merad M, Vabret N. Highlights from a year in a pandemic. J Exp Med 2021;218:e20210220. [PMID: 33835146 DOI: 10.1084/jem.20210220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
170 . Immunology shines in the dark. Nat Rev Immunol 2021;21:193-4. [PMID: 33727713 DOI: 10.1038/s41577-021-00527-w] [Reference Citation Analysis]
171 Klaric L, Gisby JS, Papadaki A, Muckian MD, Macdonald-Dunlop E, Zhao JH, Tokolyi A, Persyn E, Pairo-Castineira E, Morris AP, Kalnapenkis A, Richmond A, Landini A, Hedman ÅK, Prins B, Zanetti D, Wheeler E, Kooperberg C, Yao C, Petrie JR, Fu J, Folkersen L, Walker M, Magnusson M, Eriksson N, Mattsson-Carlgren N, Timmers PRHJ, Hwang SJ, Enroth S, Gustafsson S, Vosa U, Chen Y, Siegbahn A, Reiner A, Johansson Å, Thorand B, Gigante B, Hayward C, Herder C, Gieger C, Langenberg C, Levy D, Zhernakova DV, Smith JG, Campbell H, Sundstrom J, Danesh J, Michaëlsson K, Suhre K, Lind L, Wallentin L, Padyukov L, Landén M, Wareham NJ, Göteson A, Hansson O, Eriksson P, Strawbridge RJ, Assimes TL, Esko T, Gyllensten U, Baillie JK, Paul DS, Joshi PK, Butterworth AS, Mälarstig A, Pirastu N, Wilson JF, Peters JE. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. medRxiv 2021:2021. [PMID: 33851187 DOI: 10.1101/2021.04.01.21254789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
172 Velikova T. INFECTION-ACQUIRED VERSUS VACCINE-INDUCED IMMUNITY AGAINST COVID-19. CAJMHE 2021;2:29-35. [DOI: 10.47316/cajmhe.2021.2.1.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
173 Lazar V, Ancuta P. SARS-CoV-2 - SYNOPTIC CHART OF THE MAIN CHARACTERISTICS OF VIRUS, PATHOGENESIS, IMMUNE RESPONSE, IMMUNOPROPHYLAXIS. Roum Arch Microbiol Immunol 2021;80:51-80. [DOI: 10.54044/rami.2021.01.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Takashima K, Oshiumi H. [The innate immune response to SARS-CoV-2]. Uirusu 2021;71:33-40. [PMID: 35526992 DOI: 10.2222/jsv.71.33] [Reference Citation Analysis]
175 Mckendry R, Lemm N, Papargyris L, Chiu C. Human Challenge Studies with Coronaviruses Old and New. Current Topics in Microbiology and Immunology 2021. [DOI: 10.1007/82_2021_247] [Reference Citation Analysis]
176 [DOI: 10.1101/2020.06.08.20125179] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Reference Citation Analysis]